A Retrospective Study to Evaluate the Safety and Efficacy of Paclitaxel Combined with Ramucirumab as Second Line Therapy in Japanese Patients with Advanced Gastric Cancer
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Paclitaxel (Primary) ; Ramucirumab (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Jun 2018 Results comparing paclitaxel combined with ramucirumab as the second-line chemotherapy in younger patients versus elderly patients with advanced gastric cancer, presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 21 Jun 2017 New trial record
- 06 Jun 2017 Results (n=18) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.